Response of Yeast and Mycelial Phases of Histoplasma capsulatum to Amphotericin B and Actinomycin D
Author(s) -
S.C. Cheung,
Gerald Medoff,
David Schlessinger,
G S Kobayashi
Publication year - 1975
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.8.4.498
Subject(s) - histoplasma capsulatum , amphotericin b , dimorphic fungus , yeast , mycelium , polyene , microbiology and biotechnology , antibiotics , histoplasma , biology , fungus , histoplasmosis , antifungal , botany , biochemistry , immunology
The dimorphic fungus Histoplasma capsulatum exists in two phases: a unicellular yeast form at 37 C and a mycelium at 25 C. We have found that these two phases have selective drug susceptibilities. The mycelial form of H. capsulatum was much more susceptible to the polyene antibiotic amphotericin B than the yeast form; in contrast, the yeast form was more susceptible to the antibiotic actinomycin D. The changes in susceptibility occurred early in the transition between the two phases and permitted the transitions to be blocked by sublethal concentrations of the appropriate drugs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom